#Japan #Tokyo #Probiotics #Toa Pharmaceutical #Biosory EX

Introduction

Toa Pharmaceutical has recently introduced its latest innovation in livestock feed: Biosory® EX. This new product is designed to meet the needs of the livestock market, significantly improving productivity and animal health.

What is Biosory® EX?

Biosory® EX is a mixed feed that contains live beneficial bacteria, specifically developed to enhance gut health and productivity among livestock. Compared to its leading product, Biosory Ace, this new formulation contains double the amount of three key bacterial strains—lactic acid bacteria, butyric acid bacteria, and saccharolytic bacteria—as well as oligosaccharides, making it more effective at half the recommended feeding amount of its predecessor.

Enhanced Ingredients

In addition to the abundant bacteria, Biosory® EX now includes peptide zinc as a novel functional ingredient. This addition aims to boost productivity and support robust immune function, ensuring livestock remain healthy and efficient in their production capabilities.

Improved Usability

Biosory® EX has been formulated for maximum user convenience. It exhibits enhanced solubility in milk and warm water, increasing palatability for animals. Furthermore, its packaging allows for reduced storage space requirements, improving overall usability during operation.

Functional Benefits of Probiotics

The mixed feed features three types of beneficial bacteria that coexist and proliferate within various parts of the intestinal tract. The synergistic effects of the probiotics and prebiotics work together to optimize the gut microbiome, thereby maintaining overall health. Additionally, maintaining proper stool quality contributes positively to the cleanliness of stable environments, a crucial aspect of livestock management.

Release Schedule

Biosory® EX is set to launch soon, with the manufacturer planning to start shipments of the following packaging:

• - Aluminum bags: 10kg (1kg x10) starting on October 27, 2025
• - Kraft bags: 10kg starting on November 25, 2025

Toa Pharmaceutical is committed to supporting the livestock industry with the introduction of Biosory® EX, aiming to enhance productivity and improve management practices.

Company Overview

• - Name: Toa Pharmaceutical Co., Ltd.
• - CEO: Tomohide Masuda
• - Location: 2-1-11 Sasazuka, Shibuya-ku, Tokyo 151-0073, Japan
• - Founded: January 1948
• - Business Activities: Manufacture and sale of pharmaceuticals, quasi-drugs, animal pharmaceuticals and feeds, health foods, and food products
• - Capital: 700 million yen
• - Website: Toa Pharmaceutical

Contact Information

For further inquiries regarding this release, please contact:

• - Department: Animal Medicine Sales Department
• - Phone: 03-3375-0511
• - Email: [email protected]
• - Website: Animal Division